Aurobindo Pharma (AUROPHARMA) — Announcement

📢 Key Event
ANVISA approves CuraTeQ's biosimilics facility

💡 Investor Takeaway
The approval expands Aurobindo's biosimilics market access in Brazil and Latin America.

Aurobindo Pharma announced that its wholly owned subsidiary CuraTeQ Biologics received ANVISA approval for its biosimilars manufacturing facility in Hyderabad following a successful GMP inspection, strengthening its position to supply biosimilars to Brazil and Latin America.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AUROPHARMA ✨ Ask AI About This

About Aurobindo Pharma Limited (AUROPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹87,805.59 Cr P/E: 25.3

View full AUROPHARMA stock details →

📡 Get AI alerts when AUROPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AUROPHARMA — Free

💡 Ask AI about this filing

"How will this approval affect Aurobindo's biosimilics revenue?" "What is the timeline for product launches in Brazil?" "How does this compare to competitors' Latin American filings?"

Ask AI Free →

📊 More AUROPHARMA filings

See all AUROPHARMA filings →

🔥 Also filed on 21 July 2026

AARTIIND Aarti Industries Limited Financial Results ANTHEM Anthem Biosciences Limited Financial Results MUFIN Mufin Green Finance Limited Corporate Action ABCAPITAL Aditya Birla Capital Limited Announcement CYIENTDLM Cyient DLM Limited Financial Results KIOCL KIOCL Limited Insider Trading

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AUROPHARMA files new disclosures

Track AUROPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.